@futurenow - totally agree. Assuming they can fund this crucial acquisition of HealthNotes (and all signs are pointing in that direction given no rights issue), I think there is a lot of upside. The product suite continues to grow, take up from customers continues to expand rapidly and new strategic alliances are announced at regular intervals. Clever management teams too (both MDR and HealthNotes). Good understanding of the needs of investors too (and responsive to those needs). I am not often excited about individual stocks (as quite a few of my comments on other stocks involve criticizing management teams for sticking their collective heads in the sand or being blatantly incompetent). MDR is the small cap in my portfolio I am most excited about going forward.
Add to My Watchlist
What is My Watchlist?
